Desano Holdings Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Private

  • Employees
  • 115

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 7

  • Investments
  • 2

Desano Holdings General Information

Description

Manufacturer and developer of pharmaceutical products, preparations, and intermediates designed to meet growing demand of global treatment of HIV and malaria. The company's products include anti-viral and anti-malarial drugs as well as finished antibiotics, anti-retrovirals and cardiovascular drugs, enabling doctors across the world to treat debilitating diseases.

Contact Information

Website
www.desano.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • No.1479 Zhangheng Road
  • Zhangjiang High-tech Park
  • Shanghai, 201203
  • China
+86 021 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Desano Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Desano Holdings‘s full profile, request access.

Request a free trial

Desano Holdings Patents

Desano Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020414895-B2 Method for preparing isavuconazonium sulfate Active 25-Dec-2019 0000000000 0
AU-2020414895-A1 Method for preparing isavuconazonium sulfate Active 25-Dec-2019 0000000000
CA-3162578-A1 Method for preparing isavuconazonium sulfate Pending 25-Dec-2019 0000000000
US-20230075632-A1 Method for preparing isavuconazonium sulfate Pending 25-Dec-2019 0000000000
EP-4083039-A1 Method for preparing isavuconazonium sulfate Pending 25-Dec-2019 C07D417/14
To view Desano Holdings’s complete patent history, request access »

Desano Holdings Executive Team (3)

Name Title Board Seat Contact Info
Xiaoxia An General Manager & President
Zikun Wang Ph.D Process Director
Jingpeng Li Vice President
To view Desano Holdings’s complete executive team members history, request access »

Desano Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Desano Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Desano Holdings‘s full profile, request access.

Request a free trial

Desano Holdings Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Genuine Biotech 12-Apr-2022 00000 0000 00000 Pharmaceuticals
Norchem Pharmaceutical 27-Jan-2022 Secondary Transaction - Private 000.00 Drug Discovery
To view Desano Holdings’s complete investments history, request access »

Desano Holdings FAQs

  • When was Desano Holdings founded?

    Desano Holdings was founded in 1996.

  • Where is Desano Holdings headquartered?

    Desano Holdings is headquartered in Shanghai, China.

  • What is the size of Desano Holdings?

    Desano Holdings has 115 total employees.

  • What industry is Desano Holdings in?

    Desano Holdings’s primary industry is Pharmaceuticals.

  • Is Desano Holdings a private or public company?

    Desano Holdings is a Private company.

  • What is Desano Holdings’s current revenue?

    The current revenue for Desano Holdings is 000000.

  • Who are Desano Holdings’s investors?

    CCBT Private Equity, CCIG Capital, CICC Jia Cheng Investment Management Company, Healthib Capital, and Xiamen Torch Group Venture Capital are 5 of 21 investors who have invested in Desano Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »